Since tumor responses to mTOR inhibitor treatment are much more dramatic than responses to other agents (see Table 4) and combination treatments are only a slight improvement over single agent mTOR inhibitor treatment, single agent mTOR inhibitor treatment seems to be the best initial strategy for medical treatment of problematic TSC related tumors. Here, TSC1 is linked to neoplasm.